May
- Exclusive
- Rich List
Australia’s wealthiest 200 now control $625b
Technology is back, resources rode a roller coaster and property growth returned, giving Australia’s Rich Listers an 11pc boost to their total fortune.
- Updated
The ASX business so good ‘you can’t put a sell on it’
Analysts say Pro Medicus is one of the world’s most expensive stocks, but also one of the best.
- Exclusive
- Rich List
More than half the 11 new Rich Listers are already billionaires
Two cryptocurrency giants, an under-the-radar mattress mogul, a former mechanic and an ex-NRL player are among 17 new and returning faces on this year’s Rich List.
- No. 176
- Rich List
Rich Lister Wes Maas’ three rules for business decisions
The former NRL player has built a billion-dollar company through hard work and diversification.
How the Turner women are creating a legacy beyond Flight Centre
Graham Turner may have turned Flight Centre into a household name, but wife Jude and daughter Jo have a different approach to business.
What Rich Listers think about money – and what they teach their kids
Nine of Australia’s wealthiest people reflect on their journey with money and whether material success leads to a rich life.
- Exclusive
- Rich List
AI reshapes Rich Lister business but not their fortunes yet
Rich Listers are using AI to overhaul graphic design, advance healthcare and improve cybersecurity, but few are investing personally.
Inside the great Rich List wealth transfer
Control of vast business empires is passing to a new generation, forcing families to confront the hard questions around succession planning. Of the 200 richest Australians, 45 are over 80 and control $136.1 billion.
Biotech start-up raising $20m pre-IPO amid missed payment claims
Plasma start-up Aegros has been accused of not paying suppliers and missing payroll, put is still planning on a 2025 IPO.
April
Scott Farquhar to step down as Atlassian co-CEO
After more than two decades at the helm, the co-founder of the Nasdaq-listed software giant departs, leaving Mike Cannon-Brookes as sole charge.
- Updated
March
How this billionaire is making his staff rich
The recent surge in WiseTech’s share price means Richard White isn’t the only one making money. Staff are sitting on a $320 million fortune.
Australia’s 75 richest women now control more than $151b
The wealth of Australia’s richest 75 women soared by 30 per cent over the past year, as entrepreneurs in resources, tech, property and fashion enjoyed the fruits of a resurgent market.
Meet the next wave of self-made women
A group of emerging female founders are positioned to grow their wealth substantially in the next decade.
Rinehart blames Hancock pay gap on ‘helping women’ into mining
A 22 per cent gender pay gap at Hancock, versus a 15 per cent for all miners, is the temporary result of getting more women into the industry, Gina Rinehart says.
September 2023
CSL cracks the genetic code of haemophilia B treatment
When CSL launched its innovative haemophilia B treatment Hemgenix, patients cried.
May 2023
The three things CSL’s new CEO now has to get right
Blood Money | After Paul Perreault grew CSL revenue by $US5 billion and profit by $US1 billion, the pressure is on new CEO Paul McKenzie to keep up the growth.
How CSL became Australia’s third-largest company
Blood Money | Under Paul Perreault, CSL became one of the biggest companies in the country, but even in 2010 its Melbourne offices still looked like something out of the 1960s.
The COVID-19 jackpot that eluded CSL
CEO Paul Perreault faced a dilemma amid the rush to develop a vaccine for the coronavirus – one that resulted in the biggest disappointment of his career there.
How CSL went from ‘bloated bureaucracy’ to $145b global behemoth
Blood Money | When Brian McNamee took on the top job at Commonwealth Serum Laboratories, the government-run entity was barely worth the land it was built on.
April 2023
Blood pressure rises at Aegros, the next plasma hopeful
Eight years before CSL hit the ASX, another biotech made its way to the bourse. The trajectories of these two companies could not be more different.
